Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>In polyglutamine (polyQ) disease, the investigation of the prediction of a patient's age at onset (AAO) facilitates the development of disease‐modifying intervention and underpins the delay of disease onset and progression. Few polyQ disease studies have evaluated AAO predicted by machine‐learning algorithms and linear regression methods.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Objective</h3><p>The objective of this study was to develop a machine‐learning model for AAO prediction in the largest spinocerebellar ataxia type 3/Machado–Joseph disease (SCA3/MJD) population from mainland China.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>In this observational study, we introduced an innovative approach by systematically comparing the performance of 7 machine‐learning algorithms with linear regression to explore AAO prediction in SCA3/MJD using CAG expansions of 10 polyQ‐related genes, sex, and parental origin.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Similar prediction performance of testing set and training set in each models were identified and few overfitting of training data was observed. Overall, the machine‐learning‐based XGBoost model exhibited the most favorable performance in AAO prediction over the traditional linear regression method and other 6 machine‐learning algorithms for the training set and testing set. The optimal XGBoost model achieved mean absolute error, root mean square error, and median absolute error of 5.56, 7.13, 4.15 years, respectively, in testing set 1, with mean absolute error (4.78 years), root mean square error (6.31 years), and median absolute error (3.59 years) in testing set 2.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>Machine‐learning algorithms can be used to predict AAO in patients with SCA3/MJD. The optimal XGBoost algorithm can provide a good reference for the establishment and optimization of prediction models for SCA3/MJD or other polyQ diseases. © 2020 International Parkinson and Movement Disorder Society</p></section>

The Progression Rate of Spinocerebellar Ataxia Type 3 Varies with Disease Stage

Age is an important independent modifier of SCA3 phenotype severity

Visual Prediction of the Progression of Spinocerebellar Ataxia Type 3 Based on Machine Learning

(CAG)n loci as genetic modifiers of age-at-onset in patients with Machado-Joseph disease from mainland China.

Spinocerebellar Ataxia Type 8 Presents As Progressive Supranuclear Palsy.

New Model for Estimation of the Age at Onset in Spinocerebellar Ataxia Type 3

The Natural History of Spinocerebellar Ataxia Type 3 in Mainland China: A 2-Year Cohort Study.

(Cag)n Loci As Genetic Modifiers of Age at Onset in Patients with Spinocerebellar Ataxia Type 1 from Mainland China.

Phenotype and Genotype Features of 187 Patients with Spinocerebellar Ataxia Type 3

Multimodal, Longitudinal Profiling of SCA1 Identifies Predictors of Disease Severity and Progression

Genotype-phenotype correlation in 667 Chinese families with spinocerebellar ataxia type 3

Prediction of Individual Disease Progression Including Parameter Uncertainty in Rare Neurodegenerative Diseases: The Example of Autosomal-Recessive Spastic Ataxia Charlevoix Saguenay (ARSACS)

Interplay of Repeat Expansion Genes in Spinocerebellar Ataxia Type 3 (P5.079)

Clinical Features and Genetic Characteristics of Homozygous Spinocerebellar Ataxia Type 3.

Prediction of the Age at Onset of Spinocerebellar Ataxia Type 3 with Machine Learning

Related Factors of ICARS and SARA Scores on Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.

Genetic and clinical profiles in a large cohort of Chinese individuals with spinocerebellar ataxia type 1

Spinocerebellar Ataxia Type 3 Pathophysiology—Implications for Translational Research and Clinical Studies

High Serum GFAP Levels in SCA3/MJD May Not Correlate with Disease Progression

Two Novel SNPs in ATXN3 3' UTR May Decrease Age at Onset of SCA3/MJD in Chinese Patients.

Genetic Profile And Clinical Characteristics Of Chinese Patients With Spinocerebellar Ataxia Type 2: A Multicenter Experience Over 10 Years